mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.8 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0096 |
0.8 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.0098 |
0.8 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.8 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |